Advertisement

Obesity Surgery

, Volume 19, Issue 3, pp 351–356 | Cite as

Increase of Osteopontin Plasma Concentrations After Bariatric Surgery Independent from Inflammation and Insulin Resistance

  • Georg SchallerEmail author
  • Yoshimasa Aso
  • Gerit-Holger Schernthaner
  • Hans-Peter Kopp
  • Toshihiko Inukai
  • Stefan Kriwanek
  • Guntram Schernthaner
Research Article

Abstract

Background

Osteopontin (OPN) is a multifunctional matrix glycoprotein associated with bone metabolism and has been linked to chronic inflammation, insulin resistance, and atherosclerosis. Diet-induced weight loss decreases elevated OPN concentrations in obese patients. The aim of the current study was to investigate the role of OPN after bariatric surgery, where not only improvements of chronic inflammation, insulin resistance and comorbidities, but also malabsorption and altered bone metabolism have been reported.

Methods

OPN plasma concentrations were determined in 31 morbidly obese patients (5 men, 26 women, BMI 46.2 ± 7.1 kg/m2, age 41 ± 11 years; mean ± SD) before and 18 months after bariatric surgery, together with parameters of bone metabolism and inflammation.

Results

OPN concentrations increased by +20.3 ± 26.6 ng/ml (mean ± SD, p < 0.01), concomitant to a weight loss of −38 ± 22 kg, and a decrease in BMI by −13.1 ± 7.7 kg/m2 (both p < 0.01). HOMA-index improved from 5.2 ± 3.4 to 1.5 ± 1.0 (p < 0.01). Calcium concentrations slightly decreased, and phosphate increased (−0.06 ± 0.13 mmol/l and +0.08 ± 0.16 mmol/l, respectively; both p < 0.05), while 25-OH-VitaminD3 remained unchanged and PTH tended to increase (+5.1 ± 14.0 pg/ml, p = 0.054). Monocyte chemoattractant protein 1 and interleukin 18 were significantly decreased and associated with HOMA both before and after bariatric surgery. ΔOPN was correlated with ΔPTH, but not with other parameters.

Conclusions

OPN plasma concentrations increased concomitant to weight loss after bariatric surgery, which was independent from an improvement of insulin sensitivity and a decrease of inflammatory markers. Further studies are needed to differentiate whether these changes in bone metabolism after bariatric surgery are secondary to calcium deficiency or an adaptation to weight loss.

Keywords

Osteopontin Morbid obesity Bariatric surgery Bone metabolism Inflammation 

Notes

Disclosure

The authors have nothing to disclose.

References

  1. 1.
    Yamaguchi H, Igarashi M, Hirata A, et al. Progression of diabetic nephropathy enhances the plasma osteopontin level in type 2 diabetic patients. Endocr J. 2004;51:499–504.CrossRefGoogle Scholar
  2. 2.
    Giachelli CM, Steitz S. Osteopontin: a versatile regulator of inflammation and biomineralization. Matrix Biol. 2000;19:615–22.CrossRefGoogle Scholar
  3. 3.
    Scatena M, Liaw L, Giachelli CM. Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler Thromb Vasc Biol. 2007;27:2302–9.CrossRefGoogle Scholar
  4. 4.
    Gomez-Ambrosi J, Catalan V, Ramirez B, et al. Plasma osteopontin levels and expression in adipose tissue are increased in obesity. J Clin Endocrinol Metab. 2007;92:3719–27.CrossRefGoogle Scholar
  5. 5.
    Kiefer FW, Zeyda M, Todoric J, et al. Osteopontin expression in human and murine obesity: extensive local upregulation in adipose tissue but minimal systemic alterations. Endocrinology. 2008;149(3):1350–7.CrossRefGoogle Scholar
  6. 6.
    Nomiyama T, Perez-Tilve D, Ogawa D, et al. Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice. J Clin Invest. 2007;117:2877–88.CrossRefGoogle Scholar
  7. 7.
    Bruun JM, Stallknecht B, Helge JW, et al. Interleukin-18 in plasma and adipose tissue: effects of obesity, insulin resistance, and weight loss. Eur J Endocrinol. 2007;157:465–71.CrossRefGoogle Scholar
  8. 8.
    Dahlman I, Kaaman M, Olsson T, et al. A unique role of monocyte chemoattractant protein 1 among chemokines in adipose tissue of obese subjects. J Clin Endocrinol Metab. 2005;90:5834–40.CrossRefGoogle Scholar
  9. 9.
    De Lemos JA, Morrow DA, Blazing MA, et al. Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z trial. J Am Coll Cardiol. 2007;50:2117–24.CrossRefGoogle Scholar
  10. 10.
    Kim MS, Day CJ, Morrison NA. MCP-1 is induced by receptor activator of nuclear factor-{kappa}B ligand, promotes human osteoclast fusion, and rescues granulocyte macrophage colony-stimulating factor suppression of osteoclast formation. J Biol Chem. 2005;280:16163–9.CrossRefGoogle Scholar
  11. 11.
    Schernthaner G, Morton JM. Bariatric surgery in patients with morbid obesity and type 2 diabetes. Diabetes Care. 2008;31 Suppl 2:S297–302.CrossRefGoogle Scholar
  12. 12.
    Sjöström L, Narbro K, Sjöström CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741–52.CrossRefGoogle Scholar
  13. 13.
    Schernthaner GH, Kopp HP, Kriwanek S, et al. Effect of massive weight loss induced by bariatric surgery on serum levels of interleukin-18 and monocyte-chemoattractant-protein-1 in morbid obesity. Obes Surg. 2006;16:709–15.CrossRefGoogle Scholar
  14. 14.
    Wucher H, Ciangura C, Poitou C, et al. Effects of weight loss on bone status after bariatric surgery: association between adipokines and bone markers. Obes Surg. 2008;18:58–65.CrossRefGoogle Scholar
  15. 15.
    De Prisco C, Levine SN. Metabolic bone disease after gastric bypass surgery for obesity. Am J Med Sci. 2005;329:57–61.CrossRefGoogle Scholar
  16. 16.
    Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement. Am J Clin Nutr. 1992;55:615–9S.CrossRefGoogle Scholar
  17. 17.
    Christou NV, Sampalis JS, Liberman M, et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg. 2004;240:414–23.CrossRefGoogle Scholar
  18. 18.
    Hamoui N, Anthone G, Crookes PF. Calcium metabolism in the morbidly obese. Obes Surg. 2004;14:9–12.CrossRefGoogle Scholar
  19. 19.
    Hey H, Stokholm KH, Lund B, et al. Vitamin D deficiency in obese patients and changes in circulating vitamin D metabolites following jejunoileal bypass. Int J Obes. 1982;6:473–9.PubMedGoogle Scholar
  20. 20.
    Moreiro J, Ruiz O, Perez G, et al. Parathyroid hormone and bone marker levels in patients with morbid obesity before and after biliopancreatic diversion. Obes Surg. 2007;17:348–54.CrossRefGoogle Scholar
  21. 21.
    Goode LR, Brolin RE, Chowdhury HA, et al. Bone and gastric bypass surgery: effects of dietary calcium and vitamin D. Obes Res. 2004;12:40–7.CrossRefGoogle Scholar
  22. 22.
    Christakos S, Dhawan P, Benn B, et al. Vitamin D: molecular mechanism of action. Ann N Y Acad Sci. 2007;1116:340–8.CrossRefGoogle Scholar
  23. 23.
    Beck GR Jr, Sullivan EC, Moran E, et al. Relationship between alkaline phosphatase levels, osteopontin expression, and mineralization in differentiating MC3T3-E1 osteoblasts. J Cell Biochem. 1998;68:269–80.CrossRefGoogle Scholar
  24. 24.
    Ishijima M, Rittling SR, Yamashita T, et al. Enhancement of osteoclastic bone resorption and suppression of osteoblastic bone formation in response to reduced mechanical stress do not occur in the absence of osteopontin. J Exp Med. 2001;193:399–404.CrossRefGoogle Scholar
  25. 25.
    Riedl M, Vila G, Maier C, et al. Plasma osteopontin increases after bariatric surgery and correlates with markers of bone turnover but not with insulin resistance. J Clin Endocrinol Metab. 2008;[Epub ahead of print 11 Mar 2008, retrieved from http://jcem.endojournals.org/cgi/rapidpdf/jc.2007-2383v1 on 12 Mar 2008]

Copyright information

© Springer Science + Business Media, LLC 2008

Authors and Affiliations

  • Georg Schaller
    • 1
    Email author
  • Yoshimasa Aso
    • 2
  • Gerit-Holger Schernthaner
    • 3
  • Hans-Peter Kopp
    • 1
  • Toshihiko Inukai
    • 2
  • Stefan Kriwanek
    • 4
  • Guntram Schernthaner
    • 1
  1. 1.Department of Internal Medicine IRudolfstiftung HospitalViennaAustria
  2. 2.Department of Internal Medicine, Koshigaya HospitalDokkyo University School of MedicineKoshigayaJapan
  3. 3.Department of Internal Medicine II, Division of AngiologyMedical University of ViennaViennaAustria
  4. 4.Department of SurgeryRudolfstiftung HospitalViennaAustria

Personalised recommendations